Imprimis NJOF, LLC has recalled 74,440 units of Epinephrine-Lidocaine HCl (0.25 mg/mL and 7.5 mg/mL) Preservative-Free 1mL Single-Use vials used for intraocular injection. This voluntary recall was initiated due to a lack of assurance of sterility in the manufacturing process. Patients or providers with questions should contact their healthcare professional or the manufacturer directly.
A lack of sterility assurance in a drug intended for injection into the eye can lead to serious infections, inflammation, and potential permanent vision loss. No specific injuries have been reported in the recall data.
Recall #: D-0519-2024
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.